Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 436-442

  Link, Amrey A ^a   Kino, Tomoshige ^a   Worth, James A ^a   McGuire, Jennifer L ^a   Crane, Marianna L ^b   Chrousos, George P ^a   Wilder, Ronald L ^b   Elenkov, Ilia J ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; BACTERIUM LIPOPOLYSACCHARIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12; PHOSPHODIESTERASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATORY DISEASE; MONOCYTE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION;

EID: 0033957489     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.436     Document Type: Article

References (36)

1. Fearon, D. T., and R .M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
2. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
3. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
4. Sher, A., and R. Ahmed. 1995. Immunity to infection: regulation of innate and adaptive responses to infection: new avenues and angles. Curr. Opin. Immunol. 7:471.
5. Rabinovitch, A., W. L. Suarez-Pinzon, and O. Sorensen. 1996. Interleukin 12 mRNA expression in islets correletes with β-cell destruction in NOD mice. J. Autoimmun. 9:645.
6. Germann, T., J. Szeliga, H. Hess, S. Storkel, F. J. Podlaski, M. K. Gately, E. Schmitt, and E. Rude. 1995. Administration of interleukin-12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92:4823.
7. Segal, B. M., D. M. Klinman, and E. M. Shevach. 1997. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J. Immunol. 158: 5087.
8. Fredholm, B. B., M. P. Abbracchio, G. Burnstock, J. W. Daly, T. K. Harden, K. A. Jacobsen, P. Leff, and M. Williams. 1994. Nomenclature and classification of purinoreceptors. Pharmacol. Rev. 46:143.
9. Olah, M. E., and G. L. Stiles. 1995. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35:581.
10. Burnstock, G. 1997. The past, present and future of purine nucleotides as signaling molecules. Neuropharmacology 36:1127.
11. Van Belle, H., F. Goossens, and J. Wynants. 1987. Formation and release of purine catabolites during hypoperfusion, anoxia and ischemia. Am. J. Physiol. 252:H886.
12. Giblett, E. R., J. E. Anderson, F. Cohen, B. Pollara, and H. J. Meuwissen. 1972. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:I067.
13. Huang, S., S. Apasov, M. Koshiba, and M. Sitkovsky. 1997. Role of A2a extracellular adenosine receptor-mediated signalling in adenosine-mediated inhibition of T cell activation and expansion. Blood 90:1600.
14. 2A purinergic receptor-mediated signaling in murine T cells. J. Biol. Chem. 272:25881.
15. Cronstein, B. N., D. Naime, and E. Oslad. 1993. The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92:2675.
16. Lappin, D., and K. Whaley. 1984. Adenosine receptors on human monocytes modulate C2 production. Clin. Exp. Immunol. 57:454.
17. Cronstein, B. N., S. B. Kramer, G. Weissman, and R. Hirschhorn. 1983. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med. 158:1160.
18. Marabito, L., M. C. Montesinos, D. M. Schreibman, L. Balter, L. Thompson, R. Resta, G. Carlin, M. A. Huie, and B. N. Cronstein. 1998. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J. Clin. Invest. 2:295.
19. Bouma, M. G., R. K. Stad, F. A. J. M. van den Wildenberg, and W. A. Buurman. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:4159.
20. Prabhakar, U., D. P. Brooks, D. Lipshlitz, and K. M. Esser. 1995. Inhibition of LPS-induced TNF-α production in human monocytes by adenosine (A2) receptor selective agonists. Int. J. Immunopharmacol. 17:221.
21. Sajjadi, F. G., K. Takabayashi, A. C. Foster, R. C. Domingo, and G. S. Firestein. 1996. Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors. J. Immunol. 156:3442.
22. Sullivan, G. W., Y. P. Peng, M. Marshall, and J. Linden. 1998. Adenosine inhibits TNF-α release from human monocytes by activation of the A2a receptor. FASEB J. 4:A484.
23. Le Moine, O., P. Stordeur, L. Schandené, A. Marchant, D. de Groote, M. Goldman, and J. Devière. 1996. Adenosine enhances IL-10 secretion by human monocytes. J. Immunol. 156:4408.
24. Haskó, G., C. Szabó, Z. H. Németh, V. Kvetan, S. McCarthy Pastores, and E. S. Vizi. 1996, Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157:4634.
25. Czerniecki, B. J., C. Carter, L. Rivoltini, G. K. Koski, H. I. Kim, D. E. Weng, J. G. Roros, Y. M. Hijazi, S. Xu, S. A. Rosenberg, and P. A. Cohen. 1997. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J. Immunol. 159:3823.
26. van der Pouw Kraan, T. C., L. C. Boeije, R. J. Smeenk, J. Wijdenes, and L. A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med. 181:775.
27. Elenkov, I. J., E. Webster, D. E. Papanicolaou, T. A. Fleischer, G. P. Chrousos, and R. L. Wilder. 1998. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161:2586.
28. Mosmann, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1.
29. Salmon, J. E., N. Brogle, C. Brownlie, J. C. Edberg, R. P. Kimberley, B. Chen, and B. F. Erlanger. 1993. Human mononuclear phagocytes express adenosine A1 receptors. J. Immunol. 151:2775.
30. Elenkov, I. J., D. A. Papanicolaou, R. L. Wilder, and G. P. Chrousos. 1996. Modulatory effects of glucocorticoids and catecholamines on human IL-12 and IL-10 production: clinical implications. Proc. Assoc. Am. Physicians 108:374.
31. Woiciechowsky, C., A. Khursu, D. Nestler, B. Eberhardt, C. Platzer, B. Schoening, F. Gloeckner, W. R. Lanksch, H. Volk, and W. Doecke. 1998. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 4:808.
32. Coletti, L. M., D. G. Remick, G. D. Burtch, S. L. Kunkel, R. M. Strieter, and D. A. Campbell. 1990. Role of tumor necrosis factor-α in the pathophysiological alterations after hepatic ischemia/reperfusion injury in the rat. J. Clin. Invest. 85:1936.
33. Forman, M. B., C. E. Velasco, and E. K. Jackson. 1993. Adenosine attenuates reperfusion injury following regional myocardial ischaemia. Cardiovasc. Res. 27:9.
34. Cain, B. S., D. R. Meldrum, C. A. Dinarello, X. Meng, A. Banerjee, and A. H. Harken. 1998. Adenosine reduces cardiac TNF-α production and human myocardial injury following ischemia-reperfusion. J. Surg. Res. 76:117.
35. O'Sullivan, S. T., J. A. Lederer, A. F. Horgan, D. H. L. Chin, J. A. Mannick, and M. L. Rodrick. 1995. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222:482.
36. Hoskin, D. W., T. Reynolds, and J. Blay. 1994. Adenosine is a possible inhibitor of killer T-cell activation in the microenvironment of solid tumours. Int. J. Cancer 59:854.